Reliance Life Sciences Private Limited (Plant 6)

Ukraine

All drugs from this manufacturer

  • CAPETAZON

    The drug is used for the treatment of colon cancer (colorectal cancer), advanced gastric cancer, as well as locally advanced or metastatic breast cancer.

    Dosage form: tablets, film-coated

    Active substance Dosage
    capecitabine 150 mg

    ATC: L01BC06

  • CAPETAZON

    The drug is used for the treatment of colon cancer (colorectal cancer), stomach cancer, and breast cancer.

    Dosage form: tablets, film-coated

    Active substance Dosage
    capecitabine 500 mg

    ATC: L01BC06

  • ERLOTOKS

    The drug is used for the treatment of non-small cell lung cancer (as first-line therapy in the presence of certain mutations, or as maintenance therapy) and for the treatment of metastatic pancreatic cancer in combination with gemcitabine.

    Dosage form: tablets, film-coated

    Active substance Dosage
    erlotinib 25 mg

    ATC: L01XE03

  • ERLOTOX

    The drug is prescribed for the treatment of non-small cell lung cancer (as first-line therapy in the presence of certain mutations, as maintenance therapy, or after ineffective chemotherapy), as well as for the treatment of metastatic pancreatic cancer in combination with gemcitabine.

    Dosage form: tablets, film-coated

    Active substance Dosage
    erlotinib 100 mg

    ATC: L01XE03

  • ERLOTOX

    The drug is used for the treatment of non-small cell lung cancer (as first-line therapy in the presence of certain mutations, or as maintenance therapy) and for the treatment of metastatic pancreatic cancer in combination with gemcitabine.

    Dosage form: tablets, film-coated

    Active substance Dosage
    erlotinib 150 mg

    ATC: L01XE03

  • LENALIDOL

    The drug is used for the treatment of adult patients with multiple myeloma, myelodysplastic syndromes (with certain genetic abnormalities), and mantle cell lymphoma.

    Dosage form: capsules, hard

    Active substance Dosage
    lenalidomide 5 mg

    ATC: L04AX04

  • LENALIDOL

    The drug is used for the treatment of adult patients with multiple myeloma, myelodysplastic syndromes (with certain genetic abnormalities), and mantle cell lymphoma.

    Dosage form: capsules, hard

    Active substance Dosage
    lenalidomide 7.5 mg

    ATC: L04AX04

  • LENALIDOL

    The drug is used for the treatment of adult patients with multiple myeloma, myelodysplastic syndromes (with certain genetic abnormalities), and mantle cell lymphoma.

    Dosage form: capsules, hard

    Active substance Dosage
    lenalidomide 10 mg

    ATC: L04AX04

  • LENALIDOL

    The drug is prescribed for the treatment of adult patients with multiple myeloma, myelodysplastic syndromes (with certain genetic abnormalities), and mantle cell lymphoma.

    Dosage form: capsules, hard

    Active substance Dosage
    lenalidomide 15 mg

    ATC: L04AX04

  • LENALIDOL

    The drug is used for the treatment of adult patients with multiple myeloma, myelodysplastic syndromes (with certain genetic abnormalities), and mantle cell lymphoma.

    Dosage form: capsules, hard

    Active substance Dosage
    lenalidomide 20 mg

    ATC: L04AX04

  • LENALIDOL

    The drug is used to treat adult patients with multiple myeloma, myelodysplastic syndromes (with certain genetic abnormalities), and mantle cell lymphoma.

    Dosage form: capsules, hard

    Active substance Dosage
    lenalidomide 25 mg

    ATC: L04AX04